Hydrocortisone improved haemodynamics and fluid requirement in surviving but not non-surviving of severely burned patients

Burns

Volumn 29, Issue 7, 2003, Pages 717-720

  Winter, W ^a   Kamolz, L ^a   Donner, A ^a   Hoerauf, K ^a   Blaicher, A ^a   Andel, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Enddiastolic volume index; Norepinephrine; Vasopressor dependent

Indexed keywords

HYDROCORTISONE; NORADRENALIN;

ADULT; AGED; ARTICLE; BURN; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; FLUID BALANCE; FLUID THERAPY; HEMODYNAMIC MONITORING; HUMAN; MALE; PATIENT; SEPSIS; SURVIVAL;

EID: 0141958048     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(03)00148-7     Document Type: Article

References (18)

1. Gang R.K., Sanyal S.C., Bang R.L., Mokaddas E., Lari A.R. Staphylococcal septicaemia in burns. Burns. 26(4):2000;359-366.
2. Anlatici R., Ozerdem O.R., Dalay C., Kesiktas E., Acarturk S., Seydaoglu G. A retrospective analysis of 1083 Turkish patients with serious burns. Part 2. Burn care, survival and mortality. Burns. 28(3):2002;239-243.
3. Briegel J., Forst H., Haller M., Schelling G., Kilger E., Kuprat G.et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 27(4):1999;723-732.
4. Knabl J.S., Bauer W., Andel H., Schwendenwein I., Dado P.F., Mittlbock M.et al. Progression of burn wound depth by systemical application of a vasoconstrictor: an experimental study with a new rabbit model. Burns. 25(8):1999;715-721.
5. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20(6):864-74.
6. Tobiasen J., Hiebert J.M., Edlich R.F. The abbreviated burn severity index. Ann Emer Med. 11(5):1982;260-262.
7. Vincent J.L., Moreno R., Takala J., Willatts S., De Mendonca A., Bruining H.et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22(7):1996;707-710.
8. Altura B.M., Altura B.T. Peripheral vascular actions of glucocorticoids and their relationship to protection in circulatory shock. J Pharmacol Exp Ther. 190(2):1974;300-315.
9. Walker B.R., Williams B.C. Corticosteroids and vascular tone: mapping the messenger maze. Clin Sci (Lond). 82(6):1992;597-605.
10. Bouachour G., Tirot P., Gouello J.P., Mathieu E., Vincent J.F., Alquier P. Adrenocortical function during septic shock. Intensive Care Med. 21(1):1995;57-62.
11. James S.E., Ghosh S.J., Montgomerie J., Philp B.M., Dziewulski P. Survival of a 75% burn in a patient with longstanding Addison's disease. Burns. 28(4):2002;391-393.
12. Oppert M., Reinicke A., Graf K.J., Barckow D., Frei U., Eckardt K.U. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med. 26(12):2000;1747-1755.
13. Bollaert P.E., Charpentier C., Levy B., Debouverie M., Audibert G., Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 26(4):1998;645-650.
14. Sanchez R. Initial shock from burns. Physiopathology: therapeutic principles. Pathol Biol (Paris). 50(2):2002;82-92.
15. Schein. Plasma cortisol levels in patients with septic shock. Crit Care Med 1990;18:259-63.
16. Tayek. Pituitary adrenal axis function in systemic inflammatory response syndrome. Endocrine 1995;3:315-18.
17. Annane D., Sharshar T., Auriant I., Clair B., Raphael J.C., Gajdos P. Corticotherapy in severe infectious states. Bull Acad Natl Med. 184(8):2000;1631-1640.
18. Loisa P., Rinne T., Kaukinen S. Adrenocortical function and multiple organ failure in severe sepsis. Acta Anaesthesiol Scand. 46(2):2002;145-151.